The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial

Table 1

Demographic characteristics of the study patients.

Characteristics	BPAL-7 regimen (n = 107)	BPAL-10 regimen (n = 109)	value
Gender, male	39 (36.5)	40 (36.7)	0.888
Age	41.46 ± 13.25	44.16 ± 12.70	0.649
Cigarette smoking
Yes	4 (3.7)	7 (6.4)	0.353
No	103 (96.3)	102 (93.6)
Alcohol drinking
Yes	1 (0.9)	3 (2.7)	0.313
No	106 (99.1)	106 (97.3)

Values were demonstrated as numbers (percentages) and mean ± SD for categorical and continuous variables, respectively. Chi-square and t-tests were performed to compare categorical and continuous variables between groups, respectively. BPAL-7 and BPAL-10: bismuth-based quadruple therapies containing pantoprazole, amoxicillin, and levofloxacin for seven and ten days, respectively.